Legislation for Capping Prescription Drug Prices in State-Level Insurance Programs
Explore a new legislative model aimed at capping prescription drug prices, enhancing state-funded insurance programs through public feedback and savings validation.
Explore a new legislative model aimed at capping prescription drug prices, enhancing state-funded insurance programs through public feedback and savings validation.
Explore how CMS is regulating Pharmacy Benefit Managers under CAA 2026, seeking feedback on compensation models and data reporting requirements. Act by July 20, 2026!
Explore the regulatory changes under the Trump administration affecting Medicaid and ACA, with implications for coverage accessibility and health care costs.
Stay updated on the latest healthcare legislation, AI initiatives, and Medicare developments that shape health policy and patient care strategies.
Learn about the proposed Medicare drug price negotiation rule and its implications on the pharmaceutical industry and state regulations.
Explore the proposed federal regulation for 2029 affecting Medicare pricing strategies for drugs. Understand the implications and upcoming changes in healthcare policy.
Discover ASCO's updated 340B Drug Pricing Program policy aimed at enhancing access to oncology care for underserved populations.
Explore upcoming changes to Medicare, including premium hikes, drug pricing reforms, and telehealth expansions that benefit millions of beneficiaries.
Explore how healthcare and insurance policies drive the Democratic primary in Colorado's 8th District. Learn about key issues and candidates' positions today.
Discover how PBM ownership by insurers influences Medicare drug costs and understand the implications for pharmacies and patient access.